Skip to main content

#160889

GroClone Serum-Free BriClone Cell Culture Media

Cat. #160889

GroClone Serum-Free BriClone Cell Culture Media

Cat. #: 160889

Sub-type: Cell culture media

Availability: Please enquire for quantities and pricing

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Dublin City University

Tool Details
Handling
Application Details

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Tool name: GroClone Serum-Free BriClone Cell Culture Media
  • Alternate name: Serum-Free BriClone Cell Culture Media
  • Tool sub type: Cell culture media
  • Description: Serum-free additive designed to improve the efficiency and support optimal growth of freshly-fused hybridoma cells during the fusion and post fusion stages of antibody production and under conditions of hybridoma single cell cloning. GroClone is similar to BriClone (Cat# 160888), but is serum-free and contains no  mammalian additives.

Handling

  • Format: Liquid

Application Details

  • Application notes: GroClone addresses the same customer need as BriClone - but a different customer segment - scientists who require process predictability in a regulatory-compliant environment. It is a premium product as it is chemically defined and serum-free. GroClone thus opens up new markets not available to BriClone to researchers who need to develop cultures in an animal- free product development system (Biopharma, In Vitro Diagnostics (IVD)).

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.